Key result
High serum anticholinergic activity is linked to synergistically worse cognitive decline from white matter hyperintensities.
Why the study?
It was unclear whether cognitive impairments associated with white matter hyperintensities in normal elderly subjects are worsened by anticholinergic medications.
Does serum anticholinergic activity exacerbate cognitive impairments associated with white matter hyperintensities in normal elderly subjects?
Observational
Does serum anticholinergic activity exacerbate cognitive impairments associated with white matter hyperintensities in normal elderly subjects?
High serum anticholinergic activity exacerbates cognitive impairments associated with white matter hyperintensities in elderly individuals.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for anticholinergic-WMH interaction; prospective studies needed before clinical adoption.
The authors investigated whether the cognitive impairments associated with white matter hyperintensities (WMH) in normal elderly subjects are exacerbated by any anticholinergic medications being taken by the subjects. Results showed serum anticholinergic activity (SAA) and WMH volume to have a synergistic interaction such that the cognitive decrements associated with increasing WMH volume were greatest in those older individuals in the highest quartile of the SAA distribution.
No takes yet. Share an insight, caveat, or question.
Nebes et al. (2005) conducted an observational in Cognitive impairment. Serum anticholinergic activity (SAA) vs. Lower quartiles of SAA distribution was evaluated on Cognitive decrements. High serum anticholinergic activity synergistically exacerbated cognitive decrements associated with increasing white matter hyperintensity volume in normal elderly subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: